LOS ANGELES, March 26 /PRNewswire-FirstCall/ -- Cord Blood America, Inc. , the umbilical cord blood stem cell preservation company (http://www.cordblood-america.com ) focused on bringing the life saving potential of stem cells to families nationwide and internationally, said today that its CEO, Matthew Schissler, will present at the ValueRich Small Cap Financial Expo on March 27 and 28th at the InterContinental Hotel in Miami, Florida.
The Expo features the opportunity for select small cap companies to meet with fund managers, money managers, institutional investors, research analysts and investment bankers over a two-day period. Cord Blood America will also have an exhibit at the conference.
"It is an important part of our mission to make these presentations at strategic conferences and to make sure that Wall Street understands the dynamics and achievements of Cord Blood America," said Mr. Schissler.
About Cord Blood America
Cord Blood America is the parent company of CorCell, which facilitates umbilical cord blood stem cell preservation for expectant parents and their children. Its mission is to be the most respected stem cell preservation company in the industry. Collected through a safe and non-invasive process, cord blood stem cells offer a powerful and potentially life-saving resource for treating a growing number of ailments, including cancer, leukemia, blood, and immune disorders. To find out more about Cord Blood America, Inc. , visit our website at www.corcell.com. For investor information, visit www.cordblood-america.com.
CONTACT: Paul Knopick E & E Communications 949/707-5365 pknopick@eandecommunications.com
Cord Blood America, Inc.CONTACT: Paul Knopick of E & E Communications, +1-949-707-5365,pknopick@eandecommunications.com, for Cord Blood America, Inc.
